These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Predictability of methenamine efficacy based on type of urinary pathogen and pH. Nahata MC; Cummins BA; McLeod DC; Butler R J Am Geriatr Soc; 1981 May; 29(5):236-9. PubMed ID: 7014695 [TBL] [Abstract][Full Text] [Related]
6. Determination of sensitivity of bacteria from urinary tract infections to methenamine mandelate by the disc method. GOLDIN M; HOFFMAN A Antibiotic Med Clin Ther (New York); 1955 Aug; 1(8):466-73. PubMed ID: 13239102 [No Abstract] [Full Text] [Related]
7. SOME FUNCTIONAL, PATHOLOGIC, BACTERIOLOGIC, AND CHEMOTHERAPEUTIC CHARACTERISTICS OF UNILATERAL PYELONEPHRITIS IN MAN. II. BACTERIOLOGIC AND CHEMOTHERAPEUTIC CHARACTERISTICS. STAMEY TA; PFAU A Invest Urol; 1963 Sep; 1():162-72. PubMed ID: 14077925 [No Abstract] [Full Text] [Related]
8. Infectious nephrolithiasis: results of treatment with methenamine mandelate. Jeantet A; Thea A; Ferrando U; Gaido M; Rotunno M; Martini PF; Vercellone A Contrib Nephrol; 1987; 58():233-5. PubMed ID: 3691135 [No Abstract] [Full Text] [Related]
9. EXPERIMENTAL PYELONEPHRITIS IN THE MOUSE PRODUCED BY ESCHERICHIA COLI, PSEUDOMONAS AERUGINOSA AND PROTEUS MIRABILIS. GORRILL RH; DENAVASQUEZ SJ J Pathol Bacteriol; 1964 Jan; 87():79-87. PubMed ID: 14106358 [No Abstract] [Full Text] [Related]
10. USE OF NALIDIXIC ACID IN THE TREATMENT OF URINARY TRACT INFECTIONS. WARRES HL Mo Med; 1964 Jan; 61():27-9. PubMed ID: 14073783 [No Abstract] [Full Text] [Related]
11. Methenamine mandelate with acidification: an effective urinary antiseptic in patients with neurogenic bladder. Kevorkian CG; Merritt JL; Ilstrup DM Mayo Clin Proc; 1984 Aug; 59(8):523-9. PubMed ID: 6379319 [TBL] [Abstract][Full Text] [Related]
12. EFFECTIVENESS OF AMPICILLIN AGAINST GRAM-NEGATIVE BACTERIA. IN VITRO AND IN VIVO STUDIES OF A NEW ANTIBIOTIC. ANDERSON KN; KENNEDY RP; PLORDE JJ; SHULMAN JA; PETERSDORF RG JAMA; 1964 Feb; 187():555-61. PubMed ID: 14089001 [No Abstract] [Full Text] [Related]
13. Pyelonephritis in the mouse. I. Infection experiments. Fitzpatrick FK Proc Soc Exp Biol Med; 1966 Nov; 123(2):336-9. PubMed ID: 5332447 [No Abstract] [Full Text] [Related]
14. [Trimethoprim and sulfamethoxazole (Eusaprim) in chronic urinary tract infections]. Porpáczy P Wien Klin Wochenschr; 1971 Jun; 83(24):439-41. PubMed ID: 4942385 [No Abstract] [Full Text] [Related]
16. Aperistaltic ureter in upper urinary tract infection--cause or effect? Boyarsky S; Labay P; Teague N Urology; 1978 Aug; 12(2):134-8. PubMed ID: 99855 [No Abstract] [Full Text] [Related]
17. Long-term drug therapy for urinary tract infections. Winter CC Ohio State Med J; 1967 Apr; 63(4):481-3. PubMed ID: 6041602 [No Abstract] [Full Text] [Related]
18. Formation of an insoluble condensation product from sulfamethizole and formaldehyde. DICARLO FJ; MALAMENT SG; PHILLIPS GE J Pharm Sci; 1963 Jan; 52():104. PubMed ID: 14027682 [No Abstract] [Full Text] [Related]
19. The demonstration of specific urinary anti-bodies in urinary tract infections caused by Gram-negative bacilli. Pearsall NN; Sherris JC J Pathol Bacteriol; 1966 Apr; 91(2):589-95. PubMed ID: 5331386 [No Abstract] [Full Text] [Related]
20. Continuous chemotherapy in the prevention of recurrent bacteriuria. Lancet; 1969 Feb; 1(7588):248. PubMed ID: 4178600 [No Abstract] [Full Text] [Related] [Next] [New Search]